Site icon OncologyTube

Intermediate/Poor And Favorable Risk RCC Patients

Tian Zhang, MD, Assistant Professor of Medicine, Duke Cancer Institute, Discusses Intermediate/Poor And Favorable Risk RCC Patients. At The 2019 Genitourinary Cancers Symposium In San Francisco, CA On Feb 14, 2019.

http://obroncology.com

Exit mobile version